98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ajo.2025.04.025 | DOI Listing |
Int J Risk Saf Med
September 2025
Department of Public Health, Gunma University Graduate School of Medicine, Maebashi, Japan.
Diagnostics (Basel)
August 2025
Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
From the corona virus pandemic in Japan that started with the "Diamond Princess" accident, it became clear that rapid detection, a high sensitivity, multiple diagnostic items, one-step one-base point mutation detection, a fast speed of system development, portability (small size and light weight), full automation, random access, and other conditions are required for future point-of-care testing systems. The Eprimer-SmartAmp technology that was developed possesses characteristics fully aligned with these requirements. Building upon this platform, the "GenPad" system was subsequently established.
View Article and Find Full Text PDFIntern Emerg Med
August 2025
Health Screening Department, Tengzhou Central People's Hospital, Tengzhou, China.
Einstein (Sao Paulo)
August 2025
Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy.